| dc.identifier.citation | Adieba, W. (2021). Penggunaan Klorokuin Pada Infeksi Virus Covid-19. Jawa Tengah : Institut Agama Islam Negri Kudus. Andi, P. (2021). Analisis Efektivitas Biaya Penggunaan Antibiotik Levofloksasin dan Azitromisin Pada Pasien Penderita Corona Virus Disease-2019. Makassar : Universitas Muslim Indonesia. ASHP. (2020). Assesment of evidence for COVID - 19 releated treatmens, update 5/21/2020. Bacharier. (2015). Early administration of azithromycin and prevention of severe lower respiratory tract illnesses in preschool children with a history of such illnesses: a randomized clinical trial, JAMA 2015;314:2034–44. Bacharier, L et al. ( 2015). Early Administration Of Azithromycin and Prevention Of Severe Lower Respiratory Tract Illnesses. JAMA-J. Am. Med. Assoc. 314, 2034–2044. Bahtera, D. P. (2020). Gambaran Tatalaksana Terapi Pada Pasien Covid-19 Terkonfirmasi Di Rumah Sakit X Kota Surakarta Periode Maret - Desember 2020, Surakarta : Sekolah Tinggi Ilmu Kesehatan Nasional. Barker, H. (2020). Bioinformatic characterization of angiotensin-converting enzyme 2, the entry receptor for SARS-CoV-2., bioRxiv. Bradley, J. (2020). Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis. . Clinical Microbiology and Infection, 26(12), 1622–1629. Cai Q. (2020). Experimental Treatment With Favipiravir for COVID-19: An Open-Label Control Study. Eng Beijing China. Oct;6(10):1192–8. Cascella, M. (2020). Features, evaluation and treatment coronavirus (COVID-19)., Stat pearls [internet]. Treasure Island (FL): Stat Pearls Publishing. CDC. (2020). Coronavirus Disease 2019 (COVID-19), Diakses dari https://www.cdc.gov/coronavirus/2019-ncox/index.html, pada tanggal 29 November 2021. Dehelean, C. A. (2020). SARS-CoV-2 : Repurposed Drugs and Novel Therapeutic Approaches-Insights into Chemical Structure-Biological Activity and Toxicological Screening. , Journal of Clinical Medicine. 9(7), p. 1-40. Dharma. (2011). Metodologi Penelitian keperawatan, Jakarta :CV. Trans Info Media. Dinkes, K. S. (2021). Retrieved from http://corona.samarindakota.go.id Donsu, Y. (2020). Tinjauan azitromisin pada penyakit virus korona 2019 (Covid-19), Pharmacon: J Farm Indones. 17 (2). p133-47. Du, et al. (2020). Risk for transportation, Emerg. Infect. Dis., doi: 10.3201/eid2605.200146. Eljaaly, K. (2017). Clinical Failure With and Without Empiric Atypical Bacteria Coverage In Hospitalized Adults. BMC Infect. Dis. 17, 1–7. Erna, P. (2020). Penggunaan Antibiotik Pada Pasien Covid-19 Di Rumah Sakit ‘X” KOTA SEMARANG. Fernandez-Atucha, A. (2017). Sex differences in the aging pattern of renin-angiotensin system serum peptidases. , Biol Sex Differ ;8:5:1-8. Gemmati, D. B. (2020). COVID-19 and Individual Genetic Susceptibility/Receptivity : Role of ACEI/ACE2 Genes, Immunity, Inflamation, and Coagulation. Might the Double X-Chromosome in Females be Protective Against SARS-CoV-2 Compared to the Single X-Chromosome in Males?. Int. J. Mol Sci; 2020. 10 : 3474. Guan, et al (2019). Clinical Characteristics of Coronavirus Disease 2019 in China., The New England journal of medicine. published February 2020. DOI: 10.1056/NEJMoa2002032. Available on: https://www.nejm.org/doi/full/10.1056/NEJMoa2002032. Habibzadeh, & Stoneman, E. (2020). The Novel Coronavirus: A Bird's Eye View, The International Journal of Occupational and Environmental Medicine. 11 (2): 65–71. Izzedine, H. (2020). COVID19 Therapeutic Options for Patients with Kidney Disease’, Kidney International. doi: 10.1016/j.kint.2020.03.015. Katzung, B. (2016). Basic and clinical pharmacology, Tenth Edition., Lange Medical Publications, United State.p851-99. Kemenkes. (2011). Modul Pengguaan Obat Rasional, Bina Pelayanan Kefarmasian, Jakarta. Kordzadeh-Kermani. (2020 ). Pathogenesis, clinical manifestations and complications of COVID-19., Future Microbiology, 15(13), 1287–. Lagocka, R. (2021). Favipiravir in therapy of viral infections. J Clin Med. Feb;103:62–71. . Lapostolle, F. (2020). Clinical Features of 1487 COVID 19 Patients with Outpatient Management in the Greater Paris : the COVID Call Study., Internal and Emergency Medicine, (0123456789). https://doi.org/10.1007/s11739-020-02379-z. Lavan. (2016). Predicting Risk of Adverse drug Reactions in Older Adults. Ther Adv Drug Saf; 2016. 7(1):11-22. Li M. (2021). Efficacy of oseltamivir compared with zanamivir in COPD patients with seasonal influenza virus infection: A randomized. Braz J Med Biol Res. 2021;54(2):e9542. Lina, M. (2021). Analisis perbandingan Lama Rawat Inap Pasien Terdiagnosis Covid-19 Antara Pemberian Terapi Oseltamivir Dengan Favipiravir di RSUD R. Syamsudin S.H Sukabumi. Bandung : Politeknik Piksi Ganesha. Lisni, I et al. (2021). Antibiotic Profile For Covid-19 Treatment, Bandung : Universitas Bhakti Kencana. Liu, Q. (2014). Emergence of a Novel Drug Resistant H7N9 Influenza Virus: Evidence Based Clinical Potential of a Natural IFN-α for Infection Control and Treatment. Expert Review of Anti Infective Therapy, 12(2), 165-169. Masturoh, I. (2018). Metodologi Penelitian Kesehatan, Jakarta : Kebayoran Baru. Metlay, J. (2020). Treatment of Community-Acquired Pneumonia During the Coronavirus Disease 2019 (COVID-19) Pandemic. . Annals of Internal Medicine, 1-3, doi: 10.7326/M20-2189. Nasution, N. H. (2021). Gambaran pengetahuan Masyarakat Tentang Pencegahan Covid-19 di kecematan Padangsidimpuan Batunadua, kota Padangsidimpuan. Jurnal Kesehatan Ilmiah Indonesia, Vol 6. PAPDI. (2020). Pedoman Tatalaksana Covid-19 Edisi 3., Jakarta. Paramita, S. E. (2020). Epidemiological Characteristics of COVID-19 Patients in Samarinda, East Kalimantan, Indonesia. PDPI. (2020). Pedoman Tatalaksana COVID-19 Pedoman Tatalaksana COVID-19 Edisi 3 Desember 2020. Pharmaceutical, T. (2020). China Approces First Anti-viral Drug Againts Coronavirus COVD - 19, Last Update : 2020 February 18. PPID et al. (2021). Tren Kasus Covid-19 Menurun, Pemkot Samarinda Pertimbangkan Beri Kelonggaran Secara Bertahap. Retrieved from https://ppid.samarindakota.go.id/berita/kesehatan/tren-kasus-covid-19-menurun-pemkot-samarinda-pertimbangkan-beri-kelonggaran-secara-bertahap Prabowo, R. (2013). Jurnal Ilmiah Cendekia Eksakta 55, Jurnal Ilmiah Cendekia Eksakta 2(82): 55-61. Pratiwi, R. (2017). Mekanisme Pertahanan Bakteri Patogen Terhadap AntibiotiK. Pro Life, 4 (3): 418-429. Rossignol, J. (2014). Nitazoxanide: a first-in-class broad-spectrum antiviral agent, 110: 94–103. Sartika, E. (2021). Edukasi Vitamin yang Tepat Masa Pandemi Covid-19, Medan : Sekolah Tinggi Ilmu Kesehatan Indah Medan. Setiadi, A. A. (2020). Tata Laksana Terapi Pasien dengan COVID-19: Sebuah Kajian Naratif, Jurnal Farmasi Klinik Indonesia, 9 (1): 70-94. Sieswerda, E. (2020). Recommendations For Antibacterial Therapy In Adults With COVID19–an Evidence Based Guideline, Clinical Microbiology and Infection. , 27 (1): 61-66. Sifriyani, A. D. (2020). Pemodelan Susceptible Infected Recovered (Sir) Untuk Estimasi Angka Reproduksi Covid - 19 Di Kalimantan Timur Dan Samarinda, Jurnal Media Statistika (July). 1 - 13. Simon, A. (2015). Evolution of the immune system in humans from infancy to old age. Proc Biol Sci [Internet] 2015;282(1821):20143085. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707740/. Styawan, D. A. (2020). Pandemi Covid-19 dalam Perspektif Demografi, Seminar Nasional Official Statistics, 2020(1), 182–189. https://doi.org/10.34123/. Susilo, A et al. (2020). Coronavirus disease 2019 tinjauan literatur terkini., J Penyakit Dalam .serial online]. 2020; 7(1). p45-67. DOI: 10.7454/jpdi.v7i1.415. Wang, Y. (2020). Comparative Effectiveness of Combined Favipiravir and Oseltamivir Therapy Versus Oseltamivir. J Infect Dis. 2020 Apr 27;221(10):1688–98. Whalen, K. (2019). Lippincott illustrated reviews: pharmacology 7 th ed. Philadelphia. WHO. (2020a). Coronavirus Disease 2019 (COVID-19) Pandemic, Diakses dari https://www.who.int/emergencies/disease/novel/-coronavirus-2019, pada tanggal 29 November 2021. WHO. (2020b). Coronavirus Disease 2019 (COVID-19) Pandemic, Diakses dari https://www.who.int/emergencies/disease/novel/-coronavirus-2019, pada tanggal 29 November 2021. WHO. (2020c). Coronavirus Disease 2019 (COVID-19) Pandemic., Diakses dari https://www.who.int/emergencies/disease/novel/-coronavirus-2019, pada tanggal 29 November 2021. Retrieved from https://covid19.who.int/ Widayati, L. P., & Mustika, I. (2021). Sikap Remaja Terhadap Upaya Pencegahan Penyebaran Colvid-19 Pada Orang Tanpa Gejala (OTG) di Surabaya, JI-KES (Jurnal Ilmu Kesehatan), 4(2), 36-44. Wirda, A. E. (2020). Pengaruh Pemberian edukasi Terhadap Tingkat Pengetahuan Pasien Rawat Jalan tentang Penggunaan Antibiotik Di RSUD Kanjuruhab Kabupaten Malang. Pharmaceutical Journal Of Indonesia, 6(1);57-62. Yao, T et al. (2020). A systematic review of lopinavir therapy for SARS coronavirus and MERS coronavirus-a possible reference for coronavirus disease-19 treatment option., J Med Virol 2020;92:556–63. Zhou, F et al. (2020). Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study., Lancet; published online March 2020. DOI: 10.1016/S0140-6736(20)30566-3. | id_ID |
